Thomas Licata

发表

MET–GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors

A. Borczuk, B. Halmos, E. Haura, 2017, Clinical Cancer Research.

Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

Sharyn A. Lincoln, Michael F. Wangler, J. Rosenfeld, 2021, Genetics in Medicine.

Thomas Licata, Ping Lu, 2019, Encyclopedia of Law and Economics.